Raymond James Financial Inc Wave Life Sciences Ltd. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Raymond James Financial Inc holds 15,721 shares of WVE stock, worth $109,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,721
Previous 12,715
23.64%
Holding current value
$109,732
Previous $157,000
19.11%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$127 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$87.4 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$57.7 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$47 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$44.4 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $606M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...